Synthetic cannabinoid use predicted shorter length of inpatient psychiatric hospitalization in patients with bipolar disorder, schizophrenia, and other psychotic disorders, according to the findings of a study published in Psychiatry Research. Through a retrospective study of 324 patient records from a … Read More
The post Synthetic Cannabinoid Use May Mediate Length of Psychiatric Hospital Stay appeared first on Dagga Magazine.